JH

John Hood

SA Samumed: 95 patents #1 of 19Top 6%
BT Biosplice Therapeutics: 9 patents #2 of 21Top 10%
SR Scripps Research: 3 patents #296 of 1,293Top 25%
BU Board Of Trustees Leland Stanford Jr University: 2 patents #21 of 153Top 15%
📍 Del Mar, CA: #14 of 784 inventorsTop 2%
🗺 California: #1,696 of 386,348 inventorsTop 1%
Overall (All Time): #10,791 of 4,157,543Top 1%
115
Patents All Time

Issued Patents All Time

Showing 76–100 of 115 patents

Patent #TitleCo-InventorsDate
9586977 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2017-03-07
9546185 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof Sunil Kumar K C, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta 2017-01-17
9540398 3-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta 2017-01-10
9533976 γ-diketones as WNT/β-catenin signaling pathway activators Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga 2017-01-03
9493437 β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga 2016-11-15
9493487 3-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta 2016-11-15
9475825 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta 2016-10-25
9475807 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta 2016-10-25
9446035 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2016-09-20
9408883 Essential oil of Kunzea ambigua and methods of use 2016-08-09
9381192 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof David Mark Wallace, Sunil Kumar KC 2016-07-05
9303010 β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga 2016-04-05
9233104 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2016-01-12
9221793 Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors Sunil Kumar KC 2015-12-29
9199991 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof David Mark Wallace, Sunil Kumar KC 2015-12-01
9090613 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof David Mark Wallace, Sunil Kumar KC 2015-07-28
9067939 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2015-06-30
9012472 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2015-04-21
8987298 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof David Mark Wallace, Sunil Kumar KC 2015-03-24
8921413 β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga 2014-12-30
8901150 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2014-12-02
8883822 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2014-11-11
8846714 1H-pyrazolo[3,4-β]pyridines and therapeutic uses thereof Sunil Kumar KC, David Mark Wallace 2014-09-30
8822478 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof David Mark Wallace, Sunil Kumar KC 2014-09-02
8815897 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof Sunil Kumar K C, David Mark Wallace 2014-08-26